Cleveland Clinic Bariatric & Metabolic Institute, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Bariatric & Metabolic Institute, Cleveland, OH, USA.
Curr Psychiatry Rep. 2021 Jan 12;23(2):10. doi: 10.1007/s11920-020-01218-4.
Marijuana use presents a unique challenge to bariatric surgery programs. We review the recent evidence examining marijuana use on outcomes following bariatric surgery.
Recent studies have not demonstrated an increased risk of short-term surgical complications or differences in up to 2-year weight loss following surgery among marijuana users. However, studies have demonstrated increased risks in two areas: pain management and problematic eating behaviors. Additionally, preoperative marijuana use has been linked to increased postoperative marijuana use which may undermine weight loss and increase risk for weight regain. There are still many unanswered questions regarding marijuana use and bariatric surgery, and the limited literature base has produced mixed results when considering marijuana as a contraindication for bariatric surgery. Programs must take into consideration the laws of their state, individual patterns of use, and route of administration when considering whether marijuana is a contraindication for surgery.
大麻使用给减重手术项目带来了独特的挑战。我们综述了近期研究,这些研究检查了大麻使用对减重手术后结局的影响。
最近的研究并未表明大麻使用者在短期手术并发症风险增加或术后 2 年内体重减轻方面存在差异。然而,研究已经表明,在两个方面存在风险增加:疼痛管理和不良进食行为。此外,术前大麻使用与术后大麻使用增加有关,这可能会破坏减重效果并增加体重反弹的风险。关于大麻使用和减重手术仍有许多尚未解答的问题,并且当考虑将大麻作为减重手术的禁忌证时,有限的文献基础产生了不一致的结果。在考虑大麻是否为手术禁忌证时,项目必须考虑其所在州的法律、个人使用模式和给药途径。